Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-04
1991-07-30
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548229, C07D26320
Patent
active
050360892
ABSTRACT:
The present invention is novel 2-oxazolidinone analogs of nitroimidazoles; novel pharmaceutical compositions of selected analogs thereof and methods of use for the compositions as radiosensitizing or chemosensitizing agents in the treatment of hypoxic tumor cells.
REFERENCES:
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal
patent: 4371540 (1983-02-01), Lee et al.
patent: 4462992 (1984-07-01), Agrawal et al.
patent: 4581368 (1986-04-01), Ahmed et al.
patent: 4596817 (1986-06-01), Ahmed et al.
patent: 4631289 (1986-12-01), Ahmed et al.
patent: 4757148 (1988-07-01), Ahmed et al.
patent: 4797397 (1989-01-01), Suto et al.
J. Med. Chem., 1987, vol. 30, No. 11, p. 2092.
Kano et al., Tetrahedron Letters, pp. 6331-6334, vol. 28, No. 50 (1987).
Evans et al., J. Am. Chem. Soc., pp. 2127-2129, vol. 103 (1981).
Ishizuka and Kunieda, Tetrahedron Letters, pp. 4185-4188, vol. 28, No. 36 (1987).
Kleschick, et al., J. Org. Chem., pp. 3168-3169, vol. 52, No. 14 (1987).
J. Med. Chem., pp. 55-59, vol. 31, No. 1 (1988).
C.A. 102:6544 (1985).
J. Am. Chem. Soc., pp. 6395-6397, vol. 108 (1986).
Tetrahedron Letters, vol. 29, No. 1, pp. 99-102 (1988).
Daus Donald G.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
2-oxazolidinone derivatives of nitroimidazoles and pharmaceutica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutica will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542890